These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 6001633)
21. [Dynamics of the neurological indices in the treatment of lupus erythematosus]. Shaposhnikov OK; Popov AK; Sablina ME Vestn Dermatol Venerol; 1979 Apr; (4):3-7. PubMed ID: 433398 [No Abstract] [Full Text] [Related]
22. [Study of T lymphocyte subpopulations in patients with lupus erythematosus using monoclonal antibodies during immunocorrective therapy]. Berenbeĭn BA; Kagramanov GV; Slavina EG Vestn Dermatol Venerol; 1987; (3):10-3. PubMed ID: 3300088 [No Abstract] [Full Text] [Related]
23. [Lupus erythematosus; current treatment methods]. Baart de la Faille H Ned Tijdschr Geneeskd; 1992 Oct; 136(42):2052-6. PubMed ID: 1407206 [No Abstract] [Full Text] [Related]
24. [Treatment of lupus erythematosus with delagil and prednisolone]. Zenin AS Vestn Dermatol Venerol; 1966 Feb; 40(2):24-6. PubMed ID: 5973005 [No Abstract] [Full Text] [Related]
26. [Contribution to the evaluation of external factors in the pathogenesis of chronic lupus erythematodes]. Jílek M Cesk Dermatol; 1968 Apr; 43(2):104-7. PubMed ID: 5671608 [No Abstract] [Full Text] [Related]
27. [The psychiatric symptom of lupus erythematosus (2 case-reports)]. Arai M; Shimizu M; Oana Y; Sato S; Miura S Zasshi Tokyo Ika Daigaku; 1971; 29(1):43-7. PubMed ID: 5170235 [No Abstract] [Full Text] [Related]
33. [Lupus erythematosus. 5. Current status and trends in therapy of lupus erythematosus: a) S.L.E.: therapy with antimalarials, steroid therapy and monitoring, acupuncture; b) D.L.E.; c) Therapy of oral lesions and xerostomia; d) Dental treatment during L.E]. Frojo M; Palomba F; Rullo R Arch Stomatol (Napoli); 1989 Nov; 30(5):1113-25. PubMed ID: 2641870 [No Abstract] [Full Text] [Related]
34. [Chronic discoid lupus erythematosus; who is afraid of the red wolf?]. van Joost T; Stolz E; Habets W; Notowicz A Ned Tijdschr Geneeskd; 1985 Apr; 129(17):769-71. PubMed ID: 4000286 [No Abstract] [Full Text] [Related]
35. Hyperkeratotic nail discoid lupus erythematosus evolving towards systemic lupus erythematosus: therapeutic difficulties. Richert B; André J; Bourguignon R; de la Brassinne M J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):728-30. PubMed ID: 15482310 [TBL] [Abstract][Full Text] [Related]
36. [Content of the vitamin C in patients with lupus erythematosus]. Shinskiĭ GE Przegl Dermatol; 1968; 55(5):659-66. PubMed ID: 5726626 [No Abstract] [Full Text] [Related]
37. Antimalarials in the management of discoid and systemic lupus erythematosus. Dubois EL Semin Arthritis Rheum; 1978 Aug; 8(1):33-51. PubMed ID: 358397 [No Abstract] [Full Text] [Related]
38. [Subacute lupus erythematosus appearing after a treatment with norlutin of a patient with chronic lupus erythematosus]. Hadida E; Sayag J Bull Soc Fr Dermatol Syphiligr; 1968; 75(5):616-7. PubMed ID: 5702683 [No Abstract] [Full Text] [Related]
39. [Local application of "Synalar" ointment in the treatment of patients with lupus erythematosus]. Chubarova AS; Beĭlin GE; Alekseeva MI; Shifrina FI Vestn Dermatol Venerol; 1966 Apr; 40(4):80-1. PubMed ID: 5988465 [No Abstract] [Full Text] [Related]
40. [Antioxidants in the treatment of patients with discoid lupus erythematosus]. Kalamkarian AA; Samsonov VA; Olisova MO; Lashmanova AP; Polianskaia NP Vestn Dermatol Venerol; 1989; (10):29-31. PubMed ID: 2609744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]